Pages that link to "Item:Q1657816"

The following pages link to Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data (Q1657816):

Displaying 8 items.

• Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance (Q2803513) (← links)
• Poisson sequential sampling modified towards maximal safety in adverse event monitoring (Q4389807) (← links)
• Complementary hypotheses in safety surveillance (Q4965656) (← links)
• Frequentist-Bayesian Monte Carlo testing (Q5077189) (← links)
• Exact conditional maximized sequential probability ratio test adjusted for covariates (Q5379334) (← links)
• A seasonality-adjusted sequential test for vaccine safety surveillance (Q6589304) (← links)
• Alpha spending for historical versus surveillance Poisson data with CMaxSPRT (Q6625629) (← links)
• Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data (Q6627990) (← links)